Get 15% Off on World Health Day Flash Sale Get 15% Off on World Health Day Flash Sale

ADVERTISEMENT

I Will Not Be Pinkwashed: Komen's Race is for Money, Not the Cure

I Will Not Be Pinkwashed: Komen's Race is for Money, Not the Cure

Story at-a-glance -

  • The multimillion-dollar company behind all those pink “breast cancer awareness” ribbons -- the Susan G. Komen Foundation – uses less than a dime of each dollar to actually look for a breast cancer cure, as promised
  • Plastering pink ribbons on every conceivable product has much more to do with raising awareness of, and money for, the Komen Foundation than it does curing breast cancer; pink ribbon campaigns are commonly used on products that may contribute to cancer, such as fried chicken and cosmetics that contain cancer-causing ingredients
  • It’s reported that the Komen Foundation owns stock in several pharmaceutical companies, including AstraZeneca, the maker of tamoxifen, a cancer drug that is actually classified as a human carcinogen by both the World Health Organization and the American Cancer Society
  • In the case of many large cancer charities, your money will go toward research to create often-toxic and sometimes deadly cancer drugs, questionable screening programs like mammography, and into the bank accounts of its numerous well-paid executives -- all while the real underlying causes continue to be ignored or actively concealed

By Dr. Mercola

In the United States, virtually everyone has seen the "pink ribbon" campaigns plastered on everything from make-up and cupcakes to t-shirts and fried chicken buckets, and recognize the symbol as a sign of breast cancer awareness.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access